In our population, the most common diagnoses that made up this group were other primary thrombophilia (D68.59), other thrombophilia (D68.69), coagulation defect, unspecified (D68.9), activated protein C resistance (D68.51), antiphospholipid syndrome (D68.61), lupus anticoagulant syndrome (D68.62), hemorrhagic disorder due to extrinsic circulating anticoagulants (D68.32), and prothrombin gene mutation (D68.52). This evidence concerns the gene F2 and thrombophilia.